Professor Paul Ellis

Professor Ellis provides medical advisory services to HCA. In his role, Professor Ellis leads interactions with hospital medical staff and the hospital leadership team to assist by providing medical advice and promoting high quality, cost effective care.

In his role, he contributes to the strategy, policies and decision making regarding oncology treatments and advises HCA to ensure that care provided within the facility is appropriate and efficient. In his role, Professor Ellis advises on initiatives to drive clinical standards by providing professional advice on clinical governance matters and ensuring the adoption of those by colleagues in the oncology area.

In addition, he works with medical insurance companies, GPs, other relevant local NHS contacts, and patients to educate and advise on relevant clinical updates to treatments in oncology available in the facility. Furthermore, he advises on the accuracy of literature that may be published regarding relevant services. He will also advise on how to make the patient referral smooth to reduce stress and anxiety for patients.

As well as promoting successful working of the facility's Medical Advisory Committee, Integrated Governance Committee and advising the hospital's senior management team on all matters relating to medical practice within the facility, Professor Ellis is responsible for providing advice on clinical governance matters to conform with national standards and recommend new programmes to drive up clinical standards.

In addition, he supports the HCA team to recruit and retain staff as well as taking a lead role in medical staff credentialing. In his role, evaluates ongoing quality initiatives such as clinical audits and quality assurance programmes.

Professor Ellis has also been heavily involved in developing the quality of breast cancer treatment by setting up an ongoing development of HCA patients in the Support/Living Well Programme. He also sits on the Chemotherapy executive board and continues to regularly lecture, as one of the medical experts, on each of the 10 week modules. In addition, he is the clinical lead for the LOC advisory group.

All services provided under this agreement are charged to HCA. In 2019, the total paid for these services was £96,229. In 2020 (until 30 September) the total paid for these services was £138,627.

HCA requires the doctors that advise us to attest that if they also practice in the NHS that they are not compromising their NHS commitments.

The information disclosed on this page in accordance with the Private Healthcare Market Investigation Order 2014 is true and accurate to the best of HCA’s knowledge and belief.